BARDA Industry Day
Explore BARDA's Rapidly Expanding COVID-19 Medical Countermeasure Portfolio
Expanding pharmaceutical manufacturing in the US to produce medical countermeasures during the COVID-19 response and future public health emergencies
Learn how BARDA is involved in Solving Sepsis
Investing in an array of medical countermeasures to diagnose, treat, or protect against COVID-19 under the BARDA BAA
The EZ-BAA program and seeks abstract submissions for select COVID-19 medical countermeasures
Enhancing the Nation's PUBLIC HEALTH SECURITY and emergency preparedness
by facilitating communication on innovative products and solutions between federal agencies
and public stakeholders.
55 FDA Approvals , Licensures and Clearances for BARDA supported Products
14 EUAs for BARDA-supported SARS CoV-2 Diagnostic Tests
Over 77,000 patients transfused with convalescent plasma under BARDA-supported expanded access programs
COVID-19 CoronaWatch requests from every state in the USA
500+ COVID-19 CoronaWatch Virtual Market Research Meetings with innovative companies
43.5M+ Diagnostic Test Kits Shipped by BARDA supported Partners
COVID-19 contract awards in as few as 9 days
What is an
U.S. Food and Drug Administration
BARDA partners with Invirsa to develop a treatment for ocular conditio…
BARDA awards additional funds to Basilea for next steps in antibiotic…
BARDA and Luminex Corporation partner to expedite development of COVID…
2020 ASPR Strategic Plan2020-2023
National Health Security Strategy2019-2022
National Biodefense Strategy2018
PHEMCE Strategy and Implementation Plan2017-2018
PHEMCE Strategy and Implementation Plan2016
PHEMCE Stakeholders Workshop Report2016
PHEMCE Strategy and Implementation Plan2015
BARDA provides a systematic approach to the development and purchase of the necessary vaccines, drugs,
therapies, and diagnostic tools for public health medical emergencies.
ASPR focuses on preparedness planning and response; building federal emergency medical operational
capabilities; countermeasures research, and grants to strengthen the capabilities of health care systems to minimize the health impacts of public health emergencies.
NIH is responsible for conducting research to better understand public health threats and establish a
foundation for developing medical countermeasures.
FDA's responsibility is to ensure that medical countermeasures (MCMs)-such as drugs, vaccines, and diagnostic
tests-to counter these threats are safe, effective, and secure.
The CDC leads the emergency preparedness and response activities by providing strategic coordination for
activities across local, state, national, and international public health partners.
The DoD provides the military forces needed to deter war and to protect the security of our country. The
department's headquarters is at the Pentagon.
The DHS is charged with securing the nation from the many threats we face. These threats include natural and
man-made biological, chemical, radiological, and nuclear threats.